– 90% of Adults with Chronic Hepatitis Delta Virus (HDV) who Achieved Undetectable HDV RNA at 96 Weeks of Treatment with Bulevirtide Remained Undetectable for Almost 2 Years After Stopping Treatment – ...

Incyte (NASDAQ:INCY) recently announced that it had achieved positive results from both of its phase 3 studies STOP-HS1 and STOP-HS2. Both of these late-stage studies were using the company's drug ...

The error - affecting England and Wales - raises concerns about the impact on the government's approach to drug deaths.

– Substantial and durable reductions in convulsive seizure frequency observed in patients treated with 2 or 3 doses of 70mg followed by 45mg maintenance dosing on top of the best available ...

Primary endpoint of CSF HS D2S6 reduction at week 16 met; strong correlation to neurodevelopmental outcomes at 1 year, supporting HS D2S6 as surrogate biomarker reasonably likely to predict clinical ...

Sept 26 (Reuters) - Shares of Immunovant (IMVT.O), opens new tab more than doubled on Tuesday after early-stage data from its experimental antibody treatment exceeded analysts' expectations. The drug ...

Dismal numbers released Tuesday by the CDC’s National Center for Health Statistics indicate 15 percent of America's children aged five to 17 recently received treatmentt for mental health conditions ...

Real-world data show that Enhertu benefits those with HR+ breast cancer, whereas Trodelvy is effective as an initial treatment for HER2-null/HER2– disease. Enhertu (trastuzumab deruxtecan; T-DXd) ...

The Treatment & Recovery Center at 1000 W. Second Street is pictured. More than 200 people per month are coming into Douglas County’s Treatment & Recovery Center for mental health crisis, and most are ...